Key result
Comorbid anxiety or depression in COPD links to worse dyspnea and symptom scores, not hospitalizations.
Why the study?
Studies regarding the association of psychiatric comorbidities with symptom scores, spirometric variables, and hospitalizations among COPD patients are lacking, especially in India.
Does comorbid anxiety and/or depression worsen symptom scores and functional capacity in patients with COPD?
Cross-Sectional (n=128)
No
Does comorbid anxiety and/or depression worsen symptom scores and functional capacity in patients with COPD?
Comorbid depression and anxiety in COPD patients are associated with higher symptom burden and poorer quality of life, highlighting the need for psychiatric evaluation in this population.
No takes yet. Share an insight, caveat, or question.
Psychiatric comorbidities may worsen COPD symptoms; leaves open effects on spirometry and hospitalizations.
Dua et al. (2017) conducted a cross-sectional in Chronic obstructive pulmonary disease (COPD) (n=128). Comorbid anxiety and/or depression vs. No comorbid anxiety and/or depression was evaluated on Symptom scores, functional capacity, history of exacerbations/hospitalizations, and BODE index. Comorbid anxiety and/or depression in COPD patients was associated with higher dyspnea and Clinical COPD Questionnaire scores, with no significant difference in hospitalizations or BODE index.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: